IWC
CGEM icon

Integrated Wealth Concepts’s Cullinan Oncology CGEM Stock Holding History

Integrated Wealth Concepts’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.6K Buy
+1,349
New +$20K ﹤0.01% 3921

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Integrated Wealth Concepts's CGEM Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in Cullinan Oncology (CGEM) in Q2 2026: 1,349 shares worth $24.6K. The stake represents ﹤0.01% of the portfolio and ranks #3921 among its holdings.

183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Integrated Wealth Concepts held 1,349 shares of Cullinan Oncology worth $24.6K as of Q2 2026.
  • Cullinan Oncology was a new Integrated Wealth Concepts position in Q2 2026.
  • Cullinan Oncology made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #3921 holding.
  • 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.